Unknown

Dataset Information

Health technology assessment of medicinal products in Greece: a 5-year (2018-2023) review of timelines and productivity.


ABSTRACT:

Objectives

To assess the health technology assessment (HTA) process in Greece from its establishment in 2018 until 2023 in terms of timeliness and productivity.

Methods

Data were collected from the HTA Committee's database and other publicly available sources. The overall study timeframe was divided into three periods: (i) July 2018-January 2020, (ii) January 2020-July 2021, and (iii) July 2021-February 2023.

Results

During the study period, a total of 1,157 applications for medicinal products (MPs) (including 219 new active substances (NAS) and orphans) were submitted to the HTA Committee. The number of HTA recommendations increased from 60 (first period) to 641 (third period), while the backlog of MPs pending HTA and price negotiations decreased from 89 and 106 (Jan

SUBMITTER: Chantzaras A 

PROVIDER: S-EPMC11563181 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature